Progress in Mind Portugal Your Psychiatry & Neurology Resource Center COVID-19 Learn more ECNP 21 Learn more Medical education resource center Do you want to learn more? Medical education resource center The Lundbeck Institute Campus – the medical education resource center in psychiatry and neurology. Learn More THINC® Focus on cognitive symptoms in depression See More Recent News AllDepressionMigraineSchizophrenia Depression 12 May, 2023 Read Time: 1 min Product Interview Que experiência têm os profissionais de saúde com a utilização da dose de 20 mg de Brintellix® para tratar os seus doentes com TDM? Saiba mais sobre a experiência do Professor Andrea Fagiolini com a dose de 20 mg no webinar que se... Depression 30 Oct, 2022 Read Time: 3 mins Congress highlights Article Highlights in depression research from APA Online 2022 Recent research findings in depression from the poster session at APA Online 2022 covered topics... Depression, Schizophrenia 18 Oct, 2022 Read Time: 5 mins Article Strategies for precision prescribing in psychiatry In a symposium at CINP 2022 entitled ‘Strategies for Precision Prescribing in Psychiatry,’ Prof... Mental Health 04 Oct, 2022 Read Time: 4 mins Congress highlights Article Benefits of measurement-based care in psychiatry Dr Erik Vanderlip (Oregon Health & Science University, USA) was involved in forming the Workgroup... Alzheimer's Disease, Parkinson's Disease 20 Sep, 2022 Read Time: 3 mins Congress highlights Article Will artificial intelligence replace or augment physicians? Artificial intelligence (AI) is already disrupting healthcare in many areas. Will it eventually... Migraine 19 Sep, 2022 Read Time: 3 mins Satellite symposium Article Assessing patient disability is vital for successful treatment of migraine When measuring the success of migraine treatment, it is easy to focus on clinical features like... Migraine 15 Sep, 2022 Read Time: 3 mins Satellite symposium Article Anti-CGRP monoclonal antibody therapy for migraine prevention in the real world Long-term clinical studies and real-world evidence are providing supportive data on the efficacy,... Migraine 14 Sep, 2022 How migraine can impact a person’s life when they are experiencing a migraine attack Professor Cristina Tassorelli sat down with us at EAN 2022 to introduce herself and discuss how... Migraine 13 Sep, 2022 Read Time: 5 mins Satellite symposium Article Experts’ perspectives on managing chronic migraine in their own clinical practice Three experts from different countries provided perspectives on their own clinical practice managing... Migraine 12 Sep, 2022 Read Time: 3 mins Congress highlights Article Raising the healthcare prioritization of headache: Why and how? Headache is the most common neurologic disorder but the least acknowledged, said Professor Rigmor... Migraine 12 Sep, 2022 Read Time: 4 mins Satellite symposium Article New real-world data on the use of calcitonin gene-related peptide monoclonal antibodies for migraine prevention New real-world data on the effectiveness, tolerability, and other benefits of migraine prevention... Schizophrenia 07 Sep, 2022 Read Time: 3 mins Congress highlights Article Interventions to improve real-life functioning Accurate assessment of neurocognition and social cognition and personalized cognitive training and... Migraine 30 Aug, 2022 Read Time: 3 mins Satellite symposium Article What can be done to lower the economic cost of migraine? The annual economic cost of migraine is high — estimated to be €50–111 billion in Europe in 2011.... Mental Health 24 Aug, 2022 Read Time: 3 mins Congress highlights Article How do psychiatric comorbidities affect migraine and its treatment? Patients with migraine often have psychiatric comorbidities. This can affect disease severity and... Migraine 21 Jul, 2022 Read Time: 3 mins Congress highlights Article Migraine research poster highlights from AAN Virtual 2022 Highlights of latest migraine research from the AAN Virtual 2022 poster session included use of... Migraine 18 Jul, 2022 Read Time: 6 mins Satellite symposium Article How to address the full impact of migraine In this symposium held at the 8th Congress of the European Academy of Neurology, Vienna, June 24−28... Migraine 01 Jul, 2022 Read Time: 4 mins Satellite symposium Article Raising the bar for successful migraine prevention A 75% reduction in migraine days can be achieved in up to one-third of patients with chronic migraine... Migraine 30 Jun, 2022 Read Time: 3 mins Congress highlights Article Do US Emergency Departments Use Recommended Migraine Treatments? Millions of patients visit emergency departments (EDs) every year due to headaches, but how good is... Mental Health 28 Jun, 2022 Read Time: 3 mins Congress highlights Article Highlights from EAN 2022 — Day 4 — June 28th Welcome to Progress in Mind’s live coverage of EAN 2022. This 8th Congress of the European Academy of... Mental Health 27 Jun, 2022 Read Time: 3 mins Congress highlights Article Highlights from EAN 2022 — Day 3 — June 27th Welcome to Progress in Mind’s live coverage of EAN 2022. This 8th Congress of the European Academy of... Mental Health 26 Jun, 2022 Read Time: 3 mins Congress highlights Article Highlights from EAN 2022 — Day 2 — June 26th Welcome to Progress in Mind’s live coverage of EAN 2022. This 8th Congress of the European Academy of... Migraine, Parkinson's Disease 26 Jun, 2022 Read Time: 3 mins Congress highlights Article Highlights from EAN 2022 — Day 1 — June 25th Welcome to Progress in Mind’s live coverage of EAN 2022. This 8th Congress of the European Academy of... Migraine 14 Jun, 2022 Read Time: 3 mins Satellite symposium Article The spectrum of medication overuse headache risk factors and treatments What makes migraine worse? A plenary session at the AHS hybrid meeting 2022 addressed exactly this... Alzheimer's Disease 05 Jun, 2022 Read Time: 3 mins Congress highlights Article Targeting tau – homing-in on effective therapies in Alzheimer’s disease Several new and highly promising therapeutics for the management and possible prevention of... Schizophrenia 25 May, 2022 Read Time: 3 mins Congress highlights What is happening in the brain during schizophrenia? Neuroimaging reveals loss of brain gray matter volume in schizophrenia. New insights into the... Migraine 26 Apr, 2022 Read Time: 4 mins Satellite symposium Article Getting a head start on Migraine Prevention Migraine prevention is important to patients and clinicians. A recent Consensus Statement on... Migraine 21 Apr, 2022 Read Time: 2 mins Congress highlights New insights from a poster at IHC2021 on how patients respond when switched from one anti-CGRP monoclonal antibody to another What is the effect of switching to a second anti-CGRP monoclonal antibody when migraine fails to... Migraine 19 Apr, 2022 Read Time: 3 mins Congress highlights New disease-specific treatments for migraine prevention Preventive migraine treatment has been fundamentally changed by the development of treatments... Migraine 07 Mar, 2022 Read Time: 2 mins Satellite symposium Article What do migraine and gut disorders have in common? Nausea, vomiting, and delayed gastric emptying are symptoms of migraine and certain disorders of... Depression 07 Mar, 2022 Read Time: 3 mins Satellite symposium What’s happening in the brain in major depressive disorder? Many different combinations of symptoms lead to a diagnosis of depression, and the many different... Mental Health 03 Mar, 2022 Read Time: 3 mins Congress highlights Current practice with e-mental health and future standards E-mental health is the future for improved mental health delivery at all stages of the patient... PTSD, Depression 28 Feb, 2022 Read Time: 3 mins Congress highlights Where and how are fear memories stored in the brain? When we experience fear, what happens to the memory of the fear in our brain? What happens in our... Parkinson's Disease 22 Feb, 2022 Read Time: 2 mins Congress highlights The link between restless nights and Parkinson’s disease Rapid eye movement sleep behavior disorder is characterized by abnormal sounds and movements during... Schizophrenia 18 Feb, 2022 Read Time: 3 mins Congress highlights Article New 2021 guidelines for the treatment of schizophrenia are now available in Japan The new evidence-based guidelines for the pharmacological therapy of schizophrenia from the Japanese... Parkinson's Disease 17 Feb, 2022 Read Time: 3 mins Congress highlights Will artificial intelligence outperform clinical judgement in the near future? A thought-provoking final debate closed MDS Virtual Congress 2020. The motion—Will artificial... Migraine 15 Feb, 2022 Read Time: 3 mins Congress highlights Focus on general migraine burden and during pregnancy in Arab countries During a regional symposium of the Pan-Arab Union of Neurological Societies (PAUNS) held at #WCN2021,... Schizophrenia 14 Feb, 2022 Read Time: 2 mins Congress highlights Can we predict the future of patients with early-episode psychosis? The ability to better predict patient outcomes would be highly valuable to clinicians, allowing the... Depression 10 Feb, 2022 Read Time: 4 mins Satellite symposium The metabolic interplay between motivation, anxiety and depression There are major differences in individuals’ motivated behaviour and stress coping responses. Genetic... Migraine 09 Feb, 2022 Read Time: 2 mins Congress highlights New insights from posters at IHC2021 — migraine and body mass index and the everyday burden of migraine What is the relationship between high body mass index and migraine? and What is the real-world burden... Schizophrenia 08 Feb, 2022 Read Time: 4 mins Satellite symposium Long-acting therapies could reduce schizophrenia relapse Relapse in schizophrenia contributes to a downward spiral in disease progression. The likelihood of... Migraine 07 Feb, 2022 Read Time: 2 mins Congress highlights Is communication between meningeal immune cells and neurons a critical factor in migraine? How might meningeal immune cells influence neural activity and lead to the symptoms of migraine?... Migraine 30 Dec, 2021 Read Time: 2 mins Congress highlights Impact of abuse on migraine symptoms and comorbidity Emotional, physical, and sexual abuse are associated with an increased risk for developing migraine.... Migraine 16 Dec, 2021 Read Time: 3 mins Satellite symposium What happens in the brain and meninges during a migraine attack? Understanding the relationships between brain activation and migraine symptoms is fundamental to... Schizophrenia 06 Dec, 2021 Read Time: 4 mins Satellite symposium The COVID-19 pandemic and mental health - impact and implications One of the goals of the European College of Neuropsychopharmacology (ECNP) is to facilitate the... Migraine 06 Dec, 2021 Read Time: 3 mins Congress highlights New insights from posters at IHC2021 on how COVID-19 tests and lockdowns have affected patients with migraine Does a nasopharyngeal swab for COVID-19 trigger migraineand what has been the impact of COVID-19... Depression, Schizophrenia 02 Dec, 2021 Read Time: 5 mins Satellite symposium Exploring life engagement in major depressive disorder (MDD) and schizophrenia – mechanisms, measurement, and meaning Functional recovery is a key goal in treatment of major depressive disorder and schizophrenia. In an... Migraine 01 Dec, 2021 Read Time: 4 mins Congress highlights The omics and migraine The omics — genomics, epigenomics, pharmacogenomics, proteomics and metabolomics — are increasing... Depression 17 Nov, 2021 Read Time: 2 mins Congress highlights Melancholic MDD: different presentation and treatment but same response Even if melancholic features represent more severe depression, clinicians seem to have developed... Load More Depression 30 Jun, 2021 Read Time: 4 mins Satellite symposium Exploring the interplay between COVID-19 and major depressive disorder The COVID-19 pandemic represents a ‘triple threat’, impacting not only the physical health of... Depression 02 Jun, 2021 Read Time: 2 mins Congress highlights The Collaborative Outcomes Study on Health and Functioning During Infection Times (COH-FIT) study reports global negative effects of COVID-19 on well-being Latest data from the Collaborative Outcomes Study on Health and Functioning During Infection Times... Depression, Bipolar 20 Jan, 2021 Podcast What are the roles of abnormal metabolism and inflammation in mood disorders? Inflammation and abnormal metabolism are observed in major depressive and bipolar disorders, said... Depression 21 Oct, 2020 Read Time: 3 mins Congress highlights One disease or many – the complexity of major depressive disorder Should we consider major depressive disorder as a single disease entity of a collection of disorders,... Mental Health 20 Aug, 2020 Read Time: 2 mins Congress highlights Could sleep disturbances link migraine and mood disorders? People who have migraine are more likely to have a mood disorder than people who do not have... Mental Health 20 Jul, 2020 Read Time: 2 mins Congress highlights Digital lived-experience peer support—a major asset to achieving recovery goals Lived-experience peer support often leads to successful engagement of previously difficult-to engage... Depression, Bipolar 19 Jun, 2020 Read Time: 2 mins Congress highlights What are the roles of abnormal metabolism and inflammation in mood disorders? Inflammation and abnormal metabolism are observed in major depressive and bipolar disorders, said... Depression 27 Apr, 2020 Read Time: 3 mins Article Supporting mental health in a time of crisis The COVID-19 pandemic challenges the mental wellbeing of the general population and threatens to... Load More Migraine 30 Dec, 2021 Read Time: 2 mins Congress highlights Impact of abuse on migraine symptoms and comorbidity Emotional, physical, and sexual abuse are associated with an increased risk for developing migraine.... Migraine 16 Dec, 2021 Read Time: 3 mins Satellite symposium What happens in the brain and meninges during a migraine attack? Understanding the relationships between brain activation and migraine symptoms is fundamental to... Migraine 06 Dec, 2021 Read Time: 3 mins Congress highlights New insights from posters at IHC2021 on how COVID-19 tests and lockdowns have affected patients with migraine Does a nasopharyngeal swab for COVID-19 trigger migraineand what has been the impact of COVID-19... Migraine 01 Dec, 2021 Read Time: 4 mins Congress highlights The omics and migraine The omics — genomics, epigenomics, pharmacogenomics, proteomics and metabolomics — are increasing... Migraine 15 Nov, 2021 Read Time: 2 mins Congress highlights New insights from a poster at IHC2021 on the depiction of migraine in the media How realistic is the presentation of migraine in the media? Does it help raise awareness and lessen... Migraine 11 Nov, 2021 Read Time: 3 mins Congress highlights Insights into migraine mechanisms: a central brain disorder with peripheral inputs Speaking at #WCN2021, Professor Todd Schwedt, of the Mayo Clinic, USA summarized that although there... Mental Health 05 Nov, 2021 Read Time: 3 mins Congress highlights Highlights from ECNP 2021 — Day 4 — October 5th Welcome to Progress in Mind’s live coverage of ECNP 2021. This 34th Congress of the European College... Migraine 29 Oct, 2021 Read Time: 4 mins Congress highlights Do anti-CGRP monoclonal antibodies alter the expected course of migraine? Are anti-CGRP monoclonal antibodies disease modifying therapies for migraine? Do they alter the... Load More Mental Health 26 Jul, 2021 Read Time: 3 mins Congress highlights Psychosis in dementia or dementia in psychosis? A clinical approach to a common puzzle Overlapping and interacting problems of late-life psychosis, depression and cognitive decline –... Mental Health 26 Jul, 2021 Read Time: 3 mins Congress highlights The pandemic has permanently changed psychiatry, but perhaps not radically That was the slightly nuanced overall verdict from the debate. While 93% of the online audience... Schizophrenia 26 Jul, 2021 Read Time: 2 mins Congress highlights Rethinking ‘persistence’ in negative symptoms for better functional recovery Even short-term persistence of negative symptoms is associated with reduced clinical and real-life... Schizophrenia 26 Jul, 2021 Read Time: 3 mins Congress highlights Can people with ultra-high risk of psychosis benefit from cognitive remediation? The FOCUS study failed to show neuro- and social-cognitive benefits of cognitive remediation in... Schizophrenia 19 Jul, 2021 Read Time: 2 mins Congress highlights To screen or not to screen in first-episode psychosis There is no international consensus on whether or not to submit those experiencing first-episode... Mental Health 14 Jul, 2021 Read Time: 2 mins Congress highlights Perspectives on the future of psychiatry: treatment and training Prevention, prediction of outcome and precision in therapy emerged as themes at the EPA 2021... Schizophrenia 12 Jul, 2021 Read Time: 5 mins Congress highlights Intimacy, sexuality and psychosis – breaking the taboo Fact: Just likely everyone else, people with mental illness want to experience romance, love and... Schizophrenia 30 Jun, 2021 Read Time: 4 mins Congress highlights Finding biotypes in psychosis – newer approaches It has been known for some time that factors such as longer duration of untreated illness are grossly... Load More Most Popular